PDE4A and chronic obstructive pulmonary disease: Roflumilast, a phosphodiesterase-4 (PDE-4) inhibitor, which is used in the treatment of chronic obstructive pulmonary disease (COPD) with frequent exacerbations, can suppress oxidative stress and inflammation.